ロード中...
Stakeholder views and attitudes towards prenatal and postnatal transplantation of fetal mesenchymal stem cells to treat Osteogenesis Imperfecta
The Boost Brittle Bones Before Birth (BOOSTB4) clinical trial is investigating the safety and efficacy of transplanting fetal derived mesenchymal stromal cells (MSCs) prenatally and/or in early postnatal life to treat severe Osteogenesis Imperfecta (OI). This study aimed to explore stakeholder views...
保存先:
| 出版年: | Eur J Hum Genet |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6777523/ https://ncbi.nlm.nih.gov/pubmed/30918362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41431-019-0387-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|